Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP)
$8.05
0.00 (0.00%)
TNXP Stock Quote Delayed 30 Minutes
TNXP Stock Earnings: Tonix Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
TNXP stock results show that Tonix Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
1.50B
PE Ratio
0.07
EPS
116.93
Volume (Avg. Vol.)
1,032
Day's Range
-
52-Week Range
$0.12 - $18.40
Dividend & Yield
N/A (N/A)
TNXP Stock Predictions, Articles, and Tonix Pharmaceuticals Holding Corp. - Common Stock News
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 33% Today?
Tonix Pharmaceuticals stock is falling on Thursday after the company announced a proposed public offering for shares of TNXP.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are worth checking out on Thursday as we dig into all of the biggest news moving shares this morning!
7 F-Rated Penny Stocks to Avoid This June
There are risks associated with any investment – there’s no such thing as a surefire investment, although tools like the Portfolio Grader can make your…
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024
Discover top strong buy penny stocks, poised for impressive gains as market indices climb, offering unique opportunities.
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 40% Today?
Tonix Pharmaceuticals stock is down on Wednesday after the company announced a proposed public offering for TNXP shares.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Wednesday morning!
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 31% Today?
Tonix Pharmaceuticals stock is down on Monday after shares of TNXP underwent a one-for-32 reverse stock split to avoid delisting.
TNXP Stock Earnings: Tonix Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
TNXP stock results show that Tonix Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
TNXP Stock Earnings: Tonix Pharmaceuticals Beats EPS, Misses Revenue for Q4 2023
TNXP stock results show that Tonix Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting off Wednesday with a breakdown of the biggest pre-market stock movers investors will want to keep track of today!
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 29% Today?
Tonix Pharmaceuticals stock is taking a beating on Friday after the company revealed details of an offering for TNXP shares.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time for a dive into the biggest pre-market stock movers as we check out all of the latest news traders need to know about on Friday!
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 43% Today?
Tonix Pharmaceuticals (TNXP) stock is taking a beating on Friday after the company announced a $7 million public stock offering.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting off the day with a breakdown of all the biggest pre-market stock movers traders need to know about on Friday!
Why Is Tonix Pharmaceuticals (TNXP) Stock Up 40% Today?
TNXP stock traders are in a bidding war today as Tonix announces a possible game-changer in Covid-19 treatment methodologies.
Tonix Pharmaceuticals (TNXP) Stock Surges 15% on Patent News
While Tonix Pharmaceuticals has been embattled this year, a critical patent issuance for one of its drugs has bolstered TNXP stock.
